Home » Market News » DirectorsTalk Highlights » Over 1,200 children diagnosed with cancer in a decade, figures show
Avacta Group Plc

Over 1,200 children diagnosed with cancer in a decade, figures show

More than 1,200 children were diagnosed with some form of cancer over a 10 year period in Scotland, statistics have revealed.

From 2007 to 2016, 1,275 people aged 14 or under were recorded as having the disease and slightly more of those, 53%, were boys.

For children diagnosed between 2007 and 2011, the one-year survival rate stood at 92%, rising to over 93% by 2012 to 2016, and five-year survival figures were around 84%.

Avacta Group Plc (LON:AVCT) principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.